A total of 31 genes met these criteria (Table 1) and, among these, two of the most differentially expressed, CD133 and MMP7, were selected for evaluation in an independent series of BRCA1 tumours (see Materials and Methods). The gene discussed is MMP7; the disease is neoplasm.